Key Event Details
- An article titled "Shukra Pharmaceuticals Charts Next Chapter at NSE with Medical Technology, Al and Innovation at the Centre" was published by ANI on August 14, 2026
- The article has been carried by various media platforms subsequently
- The media coverage discusses the Company's recent listing on the National Stock Exchange of India Limited (NSE)
Listing Information
- Company's Equity Shares listed on NSE on August 14, 2026
- Shares now listed and available for trading on both BSE Limited and National Stock Exchange of India Limited
- Company describes this as "an important milestone in the Company's capital market journey"
Strategic Direction Highlights
- Article highlights Company's focus on Medical Technology
- Emphasis on Artificial Intelligence and healthcare innovation
- Focus on technology-enabled healthcare solutions
- Broader vision of leveraging technology, innovation, artificial intelligence and medical technology
- Part of Company's future growth and diversification strategy
Company Clarification
- The media article represents coverage of NSE listing and strategic vision only
- Does not represent any new material agreement, contract, order, acquisition, investment or other material transaction
- Any material transactions would be separately disclosed to Stock Exchanges in accordance with applicable laws
Additional Information
- Company CIN: L24231GJ1993PLC019079
- Factory Address: 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India
- Company Secretary and Compliance Officer: Shivkant Dhaka (ACS: 80894)
Financial Impact Assessment
No financial impact quantified in the disclosure. The filing represents a regulatory disclosure requirement regarding media coverage rather than a material financial event.